当前位置:首页 - 行情中心 - 博瑞医药(688166) - 财务分析

博瑞医药

(688166)

  

流通市值:123.70亿  总市值:123.70亿
流通股本:4.22亿   总股本:4.22亿

博瑞医药(688166)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润1.77亿元,每股收益0.45元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益244074.13万元,未分配利润82848.21万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产496578.35万元,负债252504.22万元。

利润表
报告期2023-09-302023-06-302023-03-312022-12-31
营业总收入914,877,843.44587,482,000.41304,937,396.251,017,331,488.33
营业总成本699,599,219.95462,934,616.31229,202,715.92783,330,526.79
营业利润197,956,457.28113,543,624.8875,605,620.79242,155,215.52
利润总额197,688,288.52113,276,581.7375,605,622.55242,207,221.25
净利润176,740,694.8798,389,544.2466,044,611.76211,426,956.6
其他综合收益-4,907,097.88-4,055,484.67--34,204,518.87
综合收益总额171,833,596.9994,334,059.5766,044,611.76177,222,437.73
资产负债表
报告期2023-09-302023-06-302023-03-312022-12-31
流动资产合计1,843,987,763.051,791,711,445.561,862,240,158.911,938,315,529.54
非流动资产合计3,121,795,778.283,022,350,007.482,914,793,827.342,722,956,719.3
资产总计4,965,783,541.334,814,061,453.044,777,033,986.254,661,272,248.84
流动负债合计858,888,299.17828,760,356.19859,411,521.24811,523,542.12
非流动负债合计1,666,153,937.661,632,151,072.581,548,967,860.471,608,063,533.42
负债合计2,525,042,236.832,460,911,428.772,408,379,381.712,419,587,075.54
归属于母公司股东权益合计2,377,877,547.712,296,158,944.662,305,337,559.562,191,643,269.63
股东权益合计2,440,741,304.52,353,150,024.272,368,654,604.542,241,685,173.3
负债和股东权益合计4,965,783,541.334,814,061,453.044,777,033,986.254,661,272,248.84
现金流量表
报告期2023-09-302023-06-302023-03-312022-12-31
经营活动现金流入小计768,746,032.95476,802,764.64273,596,869.871,180,877,933.45
经营活动现金流出小计669,917,583.24425,040,248.18248,536,746.66869,618,844.13
经营活动产生的现金流量净额98,828,449.7151,762,516.4625,060,123.21311,259,089.32
投资活动现金流入小计52,199,695.55442,211.0513,498,400611,704,542.89
投资活动现金流出小计419,787,403.51343,631,153.76252,701,598.691,483,280,623.3
投资活动产生的现金流量净额-367,587,707.96-343,188,942.71-239,203,198.69-871,576,080.41
筹资活动现金流入小计619,275,770.81397,187,762.46193,508,504.51,938,904,834.03
筹资活动现金流出小计552,591,997.92372,562,210.63138,084,389.52574,218,632.04
筹资活动产生的现金流量净额66,683,772.8924,625,551.8355,424,114.981,364,686,201.99
汇率变动对现金及现金等价物的影响-3,808,594.82-1,050,325.08-3,746,257.3914,151,117.73
现金及现金等价物净增加额-205,884,080.18-267,851,199.5-162,465,217.89818,520,328.63
期末现金及现金等价物余额945,850,930.37883,883,811.05989,269,792.661,151,735,010.55
TOP↑